B.C. is facing a toxic drug crisis, however, forcing people into involuntary treatment will cause more harm than good.

September is National Recovery Month. It's dedicated to promoting treatment and recovery from alcohol and drug addiction.

Central Valley leaders are asking voters to weigh in one of the oldest public policy questions: Which works better, the ...

RelateXR uses virtual reality to help recovering addicts envision the outcome of active addiction versus long-term recovery.

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

TxGNN is the first AI model specifically developed to identify drug candidates for rare diseases and conditions with no ...

Indigenous addiction treatment centres in Alberta are delaying a program developed for the province because of a lack of ...

The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...

However, only few of these medications are licensed for pediatric use, indicating it may be time to reconsider the standard treatment approach ... could receive the drug for 3-6 months while ...

Nivolumab, an immune checkpoint inhibitor lauded for its groundbreaking approach to cancer treatment, marked its 10th ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.